Company Overview

Business Development

Portola is dedicated to the discovery and development of innovative therapeutics based on targets with established proof of concept that are designed to provide significant advances over current treatments for cardiovascular disease and autoimmume/inflammatory diseases.

Companies interested in collaborating with Portola are invited to contact us to discuss our portfolio of un-partnered programs or to discuss how our research and development capabilities might be leveraged to accelerate development of novel therapeutics.

Learn more about our current product pipeline here.

For inquiries related to our business please contact: bd@portola.com.